Zhejiang Haisen Pharmaceutical Co.,Ltd.’s Net Profit Dropped 13.1% in First Three Quarters of 2023

Zhejiang Haisen Pharmaceutical Co.,Ltd. (浙江海森药业股份有限公司) (001367.SZ) reported a net profit of 71.9 million yuan in the first three quarters of 2023, down 13.1% year-on-year.

Meanwhile, the company posted 283.2 million yuan in revenue, down 10.4% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 85 million yuan in total liabilities, with a liability-to-asset ratio of 6.5%.